Description
Pubergen HP (Human Chorionic Gonadotropin) 10000 IU
Pubergen HP 10000 IU is presented as a powder for injection containing human chorionic gonadotropin, commonly abbreviated as hCG. hCG is a reproductive hormone used in fertility care and in some other hormone-related conditions. Because the exact trade name could not be independently verified from official product information, this description is based on the confirmed active ingredient rather than on the brand name alone.
Active Ingredient and Medicine Class
The active ingredient is human chorionic gonadotropin, a gonadotropin hormone. In reproductive medicine, it is used as an LH-like hormone because it can bind to luteinizing hormone/chorionic gonadotropin receptors. This pharmacological action makes it part of the gonadotropin class of medicines.
Established Medical Uses
Official prescribing information for chorionic gonadotropin products describes several established uses. These include induction of ovulation and pregnancy in appropriately selected women with anovulatory infertility after prior treatment with gonadotropins. In male patients, chorionic gonadotropin has also been used in selected cases of hypogonadotropic hypogonadism, and in some children with prepubertal cryptorchidism when anatomical obstruction is not the cause. Its fertility use is the most relevant to the product description supplied here.
How It Works
Human chorionic gonadotropin acts by mimicking the natural luteinising hormone signal. In the ovary, this signal helps complete final follicular maturation and can trigger ovulation. After ovulation, hCG also supports the corpus luteum, helping it continue progesterone production during the early luteal phase. In the testes, it can stimulate androgen production through a similar receptor-mediated pathway.
Important Safety Information
Chorionic gonadotropin products are not suitable for everyone. Official prescribing information lists important contraindications such as prior hypersensitivity to hCG or its excipients, primary gonadal failure reflected by high serum FSH in women, uncontrolled endocrine disorders, certain hormone-sensitive tumours, and reproductive tract abnormalities incompatible with pregnancy. In fertility treatment, a major concern is ovarian hyperstimulation syndrome, which can become serious or life-threatening. Other clinically important risks include multiple pregnancy, ovarian enlargement or cyst rupture, and thromboembolic reactions. Caution is also advised in people with conditions such as cardiac disease, renal disease, epilepsy, migraine, or asthma. hCG may interfere with some gonadotropin laboratory assays, particularly luteinising hormone tests.
Possible Side Effects
Reported adverse effects include headache, irritability, restlessness, fatigue, depression, oedema, and local injection-site pain or reactions. More serious reactions can include ovarian hyperstimulation syndrome, abdominal distension and pain, nausea or vomiting related to ovarian enlargement, dyspnoea, fluid accumulation, and thromboembolic events. In male use, androgen stimulation may occasionally be associated with gynecomastia or precocious puberty in susceptible paediatric patients.
Scientific Evidence
Clinical reviews and comparative studies support the role of hCG as a standard ovulation trigger in assisted reproduction. Published evidence shows that urinary hCG preparations and recombinant hCG can produce similar reproductive outcomes in infertility treatment, including oocyte retrieval and pregnancy-related endpoints. Reviews also note that hCG-triggered luteal support is effective but may increase the risk of ovarian hyperstimulation syndrome and multiple pregnancy, so its use requires careful clinical selection and monitoring. More recent reviews have also discussed that the hormonal pattern after hCG trigger is not identical to the natural cycle, which has led to ongoing refinement of fertility protocols.
Medical Information Notice
This page is an educational summary based on sources available at the time of review. It does not replace the official patient leaflet, product labelling, or assessment by a qualified healthcare professional.
Medical Sources
- FDA, Pregnyl (chorionic gonadotropin) for injection. Official prescribing information. View official FDA label
- DailyMed, Chorionic Gonadotropin for Injection, USP. Official prescribing information. View DailyMed prescribing information
- Michael Ludwig et al. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertility and Sterility, 2003. View scientific article
- Claus Yding Andersen et al. Shortcomings of an unphysiological triggering of oocyte maturation using human chorionic gonadotropin. Fertility and Sterility, 2020. View scientific article
